• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134804
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Tamponade (2226); No Code Available (3191)
Event Date 08/26/2020
Event Type  Injury  
Manufacturer Narrative
The patient code "no code available" is being used to represent the surgical intervention and prolonged hospitalization.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that an (b)(6) female patient with history of premature ventricular contractions (pvcs) underwent an idiopathic ventricular tachycardia (idvt) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring pericardiocentesis and surgical intervention.At the beginning of the procedure, the decanav catheter could not be selected for mapping.The case on the workstation was abandoned and a new case was created, and the procedure continued.Transseptal puncture was then done with a baylis rf transseptal needle, and a small pericardial effusion was discovered before any ablation had been done.The physician then decided to map and ablate with the stsf, but didn¿t want to proceed after they discovered by intracardiac echocardiography (ice) that the effusion was getting bigger during the ablation.They confirmed by transthoracic echocardiography (tte) that the effusion was bigger.The patient was sent to recovery, and while in recovery had a drop in blood pressure.Patient was brought back to the lab.It was confirmed by tte that the effusion once again increased in size.Pericardiocentesis was performed to remove an unspecified amount of fluid from the pericardial space.The patient was moved to the operating room and required open heart surgery.The physician stated the surgeon found oozing from an area near the ablation site.The patient was moved to the intensive care unit (icu) after surgery for recovery and required extended hospitalization.Patient¿s condition improved.There was no evidence of steam pop during the ablation.The catheter irrigation was set at 8ml/min.The force visualization features used were graph, dashboard, vector, and visitag.The parameters for stability used with the visitag module were 2mm x 5 seconds, 5gm 25% fot.Tag size 3mm.Impedance drop was used as color option.Since this event is life threatening and required medical intervention and prolonged hospitalization to prevent permanent impairment of a body function or permanent damage to a body structure, then it is to be considered serious and mdr-reportable.
 
Manufacturer Narrative
On 10/12/2020, the product investigation was completed as the complaint device has not been returned.It was reported that an 87-year-old female patient with history of premature ventricular contractions (pvcs) underwent an idiopathic ventricular tachycardia (idvt) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring pericardiocentesis and surgical intervention.At the beginning of the procedure, the decanav catheter could not be selected for mapping.The case on the workstation was abandoned and a new case was created, and the procedure continued.Transseptal puncture was then done with a baylis rf transseptal needle, and a small pericardial effusion was discovered before any ablation had been done.The physician then decided to map and ablate with the stsf, but didn¿t want to proceed after they discovered by intracardiac echocardiography (ice) that the effusion was getting bigger during the ablation.They confirmed by transthoracic echocardiography (tte) that the effusion was bigger.The patient was sent to recovery, and while in recovery had a drop in blood pressure.Patient was brought back to the lab.It was confirmed by tte that the effusion once again increased in size.Pericardiocentesis was performed to remove an unspecified amount of fluid from the pericardial space.The patient was moved to the operating room and required open heart surgery.The physician stated the surgeon found oozing from an area near the ablation site.The patient was moved to the intensive care unit (icu) after surgery for recovery and required extended hospitalization.Patient¿s condition improved.Device investigation details: since this event is life threatening and required medical intervention and prolonged hospitalization to prevent permanent impairment of a body function or permanent damage to a body structure, then it is to be considered serious and mdr-reportable.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.As a result, the mre review cannot be conducted.Should the correct lot number be made available at a later date, the complaint file will be reopened and an mre review will be performed and documented.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL SMART TOUCH SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key10570934
MDR Text Key208783181
Report Number2029046-2020-01258
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010176
UDI-Public10846835010176
Combination Product (y/n)N
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD134804
Device Catalogue NumberD134804
Was Device Available for Evaluation? No
Date Manufacturer Received10/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BAYLIS TRANSSEPTAL NEEDLE; CARTO 3 SYSTEM; DECANAV CATHETER
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age87 YR
-
-